Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0296558 USE OF 2AMD AND 2MD TO TREAT FIBROSIS
The invention relates to using 2-methylene-19-nor-(20S)-1.alpha.,25-(OH).sub.2D.sub.3 (2MD) or 2.alpha.-methyl-19-nor-(20S)-1.alpha.,25-(OH).sub.2D.sub.3...
2017/0296557 Methods and Compositions for Treating Psoriasis
Method and composition for treating psoriasis and other skin disorders.
2017/0296556 METHODS OF TREATING CANCER
The present invention relates to methods of treating or preventing cancer in a subject in need thereof comprising administering a therapeutically effective...
2017/0296555 TARGETING NCCA-ATP CHANNEL FOR ORGAN PROTECTION FOLLOWING ISCHEMIC EPISODE
The present invention concerns protection of an organ or tissue outside of the central nervous system following an ischemic episode. In particular aspects, the...
2017/0296554 ANTIMICROBIAL COMPOSITIONS AND METHODS OF MAKING THE SAME
The present disclosure comprises antimicrobial compositions and devices comprising silver compounds that resist heat and light discoloration. In one aspect,...
2017/0296553 MOLYBDENUM COMPOUNDS FOR USE IN THE TREATMENT OF CYANIDE POISONING
The present invention relates to compositions comprising molybdenum compounds, novel molybdenum compounds, kits and methods for their preparation. In...
2017/0296552 TRANSDERMAL DELIVERY OF DICLOFENAC, CARBAMAZEPINE AND BENZYDAMINE
The invention discloses solutions of diclofenac, carbamazepine and benzydamine, at therapeutically desirable concentrations and the solutions stable for...
2017/0296551 COMBINATION OF AURORA KINASE INHIBITORS AND ANTI-CD20 ANTIBODIES
The present invention relates to methods for the treatment of hematological malignancies. In particular, the invention provides methods for treatment of...
2017/0296550 ARYL SULTAM DERIVATIVES AS RORc MODULATORS
Compounds of the formula I: ##STR00001## or pharmaceutically acceptable salts thereof, wherein m, n, p, q, Ar, A, W, X.sup.1, X.sup.2, X.sup.3, X.sup.4, R.sup.1,...
2017/0296549 PREVENTION OF ATHEROSCLEROTIC EVENTS WITH DIRECT FACTOR Xa INHIBITORS
The use of direct factor Xa inhibitors, administered in a dose sufficient to reduce the activity of factor Xa to about 25% less than normal or lower, has the...
2017/0296548 DERIVATIVES OF 6-SUBSTITUTED TRIAZOLOPYRIDAZINES AS REV-ERB AGONISTS
The present invention provides novel 6-substituted [1,2,4]triazolo[4,3-b]pyridazines that are agonists of Rev-Erb. These compounds, and pharmaceutical...
2017/0296547 DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION COMPRISING AT LEAST ONE INHIBITOR OF SOME CHEMOATTRACTANT...
The present invention relates to the cosmetic or pharmaceutical use for a composition comprising a salicylic or nicotinic acid derivative inhibiting...
2017/0296546 SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
Provided herein are Aminopurine Compounds having the following structures: ##STR00001## wherein R.sup.1, R.sup.2, and R.sup.3 are as defined herein,...
2017/0296545 Composition Of A Ceramic Matrix With A Controlled Release Drug, A Tablet Obtained From The Composition And...
A composition of a ceramic matrix is defined by pseudoboehmite nanoparticles and is constructed for carrying and releasing medications in a controlled manner,...
2017/0296544 LIQUID FORMULATIONS OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRI- ...
A liquid formulation of (S)--N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyri- midin-3-yl)-3-hydroxypyrrolidine-1-carboxamide,...
2017/0296543 SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING BIOPTERIN DERIVATIVES AND USES OF SUCH COMPOSITIONS
The present invention relates to a method of treating a disease in a subject, comprising administering to a subject in need thereof a solid pharmaceutical...
2017/0296542 COMBINATIONS FOR THE TREATMENT OF NEOPLASMS USING QUIESCENT CELL TARGETING AND INHIBITORS OF MITOSIS
The present invention provides compositions and methods for the treatment of neoplasms, in particular, by targeting of quiescent cancer cells with therapeutic...
2017/0296541 COMBINATIONS FOR THE TREATMENT OF NEOPLASMS USING QUIESCENT CELL TARGETING WITH EGFR INHIBITORS
The present invention provides compositions and methods for the treatment of neoplasms, in particular, by targeting of quiescent cancer cells with therapeutic...
2017/0296540 METHODS OF TREATING FRIEDREICH'S ATAXIA USING SRC INHIBITORS
In one aspect, the invention presents a method of treating Friedreich's ataxia (FRDA) by administering a therapeutically effective amount of an Src inhibitor.
2017/0296539 COMPOSITE PREPARATION, CONTAINING NOVEL 3-(4--(BENZYLOXY)PHENYL)HEX-4-INOIC ACID DERIVATIVE AND ANOTHER ACTIVE ...
The present invention relates to a pharmaceutical composition for preventing or treating metabolic diseases, in which a novel ...
2017/0296538 SOLUTE AND SOLUTE MIXTURE, AS WELL AS A COMPOSITION COMPRISING AT LEAST ONE SOLUTE, FOR USE IN THE PREVENTION...
The invention relates to a compatible solute or a solute mixture, as well as to a composition comprising the solute or solute mixture, for use in the...
2017/0296537 AZABICYCLO DERIVATIVES, PROCESS FOR PREPARATION THEROF AND MEDICAL USE THEREOF
Azabicyclo derivatives, a preparation process, and medical use thereof are provided. In particular, azabicyclo derivatives of formula (I), pharmaceutically...
2017/0296536 OPHTHALMIC SUSPENSION FORMULATION
The present invention relates to a stable ophthalmic suspension formulation comprising ...
2017/0296535 METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ERYTHEMA
Methods and products for treating or preventing erythema or a symptom associated with erythema in a subject are described. The methods involve topically...
2017/0296534 USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF AUTOIMMUNE DISORDERS
The embodiments described herein include methods and formulations for treating autoimmune disorders. The methods and formulations include, but are not limited...
2017/0296533 Pharmaceutical Formulation Containing Gelling Agent
Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together...
2017/0296532 COMPOSITIONS FOR CONTROL OF DRUG ABUSE
Opiates, amphetamines, barbiturates and other drugs such as benzodiazepines are extensively abused or misused and are frequently the cause of death by...
2017/0296531 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases...
2017/0296530 Compositions and Methods for Treating and Inhibiting Viral Infections
Compositions and methods for the treatment, as well as the inhibition and prevention, of an infection of the papillomavirus and the epithelial lesions, namely,...
2017/0296529 Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Lymphoproliferative Malignancies
Methods are provided for treating a lymphoproliferative malignancy to a patient in need of such treatment, comprising administering to the patient an effective...
2017/0296528 Methods of Managing Conditioned Fear with Neurokinin Receptor Antagonists
This disclosure relates to managing conditioned fear and conditions induced by experiencing or witnessing an extreme traumatic event using neurokinin receptor...
2017/0296527 STABLE NIMODIPINE PARENTERAL FORMULATION
A nimodipine injection concentrate and diluted formulation comprises nimodipine (base or salt), an effective amount of a hydrophilic surfactant, and a...
2017/0296526 MEDICAL TREATMENTS BASED ON ANAMORELIN
Methods of treating cancer related conditions using anamorelin are described.
2017/0296525 USE OF COTININE IN TREATING OR PREVENTING NEUROGENESIS DEFICITS AND ENHANCING NEUROGENESIS
A method of inhibiting or treating chemotherapy-induced cognitive dysfunction comprising administering a therapeutically effective amount of cotinine to a...
2017/0296524 Method for Assessing the Efficacy of IMIDS and Composition or Combination for Use in Treating IMID Sensitive...
The invention relates to a combination of an immunomodulatory imide drug (IMiD) and an inhibitor of CD147 and/or an inhibitor of MCT1 for use in treating a...
2017/0296523 Pharmaceutical Compositions Comprising Alpelisib
The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide ...
2017/0296522 STABLE NIMODIPINE PARENTERAL FORMULATION
A nimodipine injection concentrate and diluted formulation comprises nimodipine (base or salt), an effective amount of a hydrophilic surfactant, and a...
2017/0296521 PHARMACEUTICAL COMPOSITION FOR SUPPRESSION OF THROMBOEMBOLISM AFTER STENT PLACEMENT
It is intended to provide a novel pharmaceutical composition that can suppress thromboembolism after stent placement. The present invention provides a...
2017/0296520 ADMINISTRATION OF BERBERINE METABOLITES
In various implementations, berberine metabolites, such as dihydroberberine and/or tetrahydroberberine, may be administered to manage blood glucose levels,...
2017/0296519 METHODS OF SEDATION DURING CRITICAL CARE TREATMENT
Methods of sedating a patient undergoing critical care treatment using intravenous gaboxadol are provided.
2017/0296518 METHOD FOR DIAGNOSING, PREVENTING, AND TREATING NEUROLOGICAL DISEASES
The invention provides for methods of treating autism associated with Desulfovibrio overgrowth in the gastrointestinal tract of a patient, said method...
2017/0296517 INHALABLE AZTREONAM FOR TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS
A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by...
2017/0296516 SELECTIVE AGONISTS OF BETA-ADRENERGIC TYPE 3 RECEPTORS (BAR3) AND USE THEREOF
Object of the present invention is the use of selective agonists of beta-adrenergic type 3 receptors (BAR3) in the treatment of nephrogenic diabetes insipidus...
2017/0296515 THIAZOLIDINONES AS CELLULAR ANANDAMIDE UPTAKE INHIBITORS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR...
The invention relates to a compound comprising the following general formula (1) for use in the treatment of psychiatric or neurological disorders and...
2017/0296514 FORMULATIONS OF DEFERASIROX AND METHODS OF MAKING THE SAME
The disclosure provides for improved pharmaceutical compositions containing deferasirox (DFX) and methods of manufacturing the same. In particular, the...
2017/0296513 COMBINATION COMPRISING A GLUCOCORTICOID AND EDO-S101
The present invention is directed to a combination comprising a glucocorticoid and a compound of formula I or a pharmaceutically acceptable salt thereof: ...
2017/0296512 3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-Y- ...
Disclosed are novel pharmaceutical compositions containing 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-- ...
2017/0296511 METHODS FOR TREATING AND PREVENTING OCULAR DISEASES, DISORDERS, AND CONDITIONS WITH MELANIN AND MELANIN...
Uses of melanin and its derivatives, analogs, and precursors for the treatment and prevention of ocular diseases, disorders, and conditions, are described....
2017/0296510 METHOD OF FORMING CONCENTRATED SOLUTION
The present invention relates to a method of forming a concentrated solution of first and second pharmacologically active ingredients which involves: providing...
2017/0296509 ACNE TREATMENT
The invention relates to the use of lipooxigenase inhibitors for treating acne, particularly inflammatory acne. The inventive lipooxigenase inhibitor can be...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.